Iradokizunak:
resolves. » resolved. (Hedatu), evolves. (Hedatu), resolveds. (Hedatu)
resolve. » resolved. (Hedatu)
resolves. » resolved. (Hedatu), evolves. (Hedatu), resolveds. (Hedatu)
resolve. » resolved. (Hedatu)
-
2621
Table1_Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice.pdf
Argitaratua 2022“...<p>Many inborn errors of metabolism require life-long treatments and, in severe conditions involving the liver, organ transplantation remains the only curative treatment. ...”
-
2622
DataSheet_1_PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer.docx
Argitaratua 2023“...The dual function of PTCH1 as a multidrug efflux pump and a hedgehog receptor, and the active involvement of CTNNB1 in breast cancer strongly indicate that PTCH1 and CTNNB1 can be potential drug targets to overcome chemoresistance in ER +/HER2- breast cancer patients....”
-
2623
Table_1_Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial...
Argitaratua 2022“...Eligible participants attended nine 30-min ISF-NF training sessions involving three cortical regions linked to pain. Feasibility measures were monitored during the trial period. ...”
-
2624
DataSheet_2_Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes.csv
Argitaratua 2023“...Introduction<p>Drug resistance is a major obstacle in cancer treatment and can involve a variety of different factors. Identifying effective therapies for drug resistant tumors is integral for improving patient outcomes....”
-
2625
Timing of Antibiotic Prophylaxis in Elective Caesarean Delivery: A Multi-Center Randomized Controlled Trial and Meta-Analysis
Argitaratua 2015“...</p><p>Methods</p><p>We conducted a randomized open-label controlled trial with two parallel arms at three hospitals in western China. Participants meeting the inclusion criteria received antibiotics 30-60 minutes before skin incision while others received antibiotics after umbilical cords clamping. ...”
-
2626
Table1_Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysis.docx
Argitaratua 2023“...</p><p>Results: There were five studies involving 492 patients included in the study. Combination therapy did not significantly improve clinical outcomes in terms of 1-year OS [RR = 1.02, 95%CI = (0.82–1.25)], 2-year OS [RR = 1.00, 95%CI = (0.67–1.49)], 4-month PFS [RR = 1.00, 95%CI = (0.67–1.49)], 1-year PFS [RR = 0.79, 95%CI = (0.44–1.42)], and ORR [OR = 0.79, 95%CI = (0.49–1.27)] compared to chemotherapy alone, and the subgroup analysis of 2-year OS, 1-year PFS, and ORR based on countries and tumor sites showed similar results. ...”
-
2627
Early Sitting in Ischemic Stroke Patients (SEVEL): A Randomized Controlled Trial
Argitaratua 2016“...Taking these limitations into account, our results may help guide the development of more effective acute stroke rehabilitation strategies, and the design of future acute stroke trials involving out of bed activities and other mobilization regimens....”
-
2628
DataSheet_1_Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes.csv
Argitaratua 2023“...Introduction<p>Drug resistance is a major obstacle in cancer treatment and can involve a variety of different factors. Identifying effective therapies for drug resistant tumors is integral for improving patient outcomes....”
-
2629
DataSheet_1_Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes.docx
Argitaratua 2023“...Introduction<p>Drug resistance is a major obstacle in cancer treatment and can involve a variety of different factors. Identifying effective therapies for drug resistant tumors is integral for improving patient outcomes....”
-
2630
Clamshell Approach for Growing Teratoma Syndrome
Argitaratua 2021“...The left superior pulmonary vein was encircled to ensure its control in case of lung involvement. The underlying left lung was freed of the compressing mass, which was a 2500 g tumor measuring 23 x 16 x 15 cm. ...”
-
2631
Robotic-Assisted Middle Lobe Sleeve Lobectomy for Carcinoid Tumor
Argitaratua 2023“...</p> <p>Preoperative bronchoscopy confirmed the involvement of the insertion of middle lobe bronchus. ...”
-
2632
Modulated Preparation and Structural Diversification of Zn<sup>II</sup> and Cd<sup>II</sup> Metal−Organic Frameworks with a Versatile Building Block 5-(4-Pyridyl)-1,3,4-oxadiazole-...
Argitaratua 2006“...Four types of binding modes involving monodentate (η-<i>N</i><sub>oxa</sub>), bidentate (μ-<i>N</i><sub>py</sub>,<i>N</i><sub>oxa</sub>, or μ-<i>N</i><sub>py</sub>,<i>S</i>,<i>S</i>) and tridentate (μ-<i>N</i><sub>py</sub>,<i>N</i><sub>oxa</sub>,<i>S</i>) are observed. ...”
-
2633
Data_Sheet_1_The efficacy and safety of different endovascular modalities for infrapopliteal arteries lesions: A network meta-analysis of randomized controlled trials.docx
Argitaratua 2022“...In total, 22 eligible RCTs (44 study arms; 1,348 patients) involving nine endovascular modalities or combinations [balloon angioplasty (BA), drug-coated balloon (DCB), drug-eluting stent (DES), atherectomy device + BA (AD + BA), AD + DCB, balloon-expandable bare metal stent (BMS), self-expanding stent (SES), absorbable metal stents (AMS), and inorganics-coated stent (ICS)] were included. ...”
-
2634
Image_1_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Argitaratua 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2635
Table_2_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Argitaratua 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2636
Table_1_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Argitaratua 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2637
Image_3_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Argitaratua 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2638
Table_3_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Argitaratua 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2639
Image_3_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Argitaratua 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2640
Image_2_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Argitaratua 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”